TEVA
LOW Impact
TEVA
Teva Pharmaceutical Reports 2025 Q1 Financial Results
|
8-K
Summary
On May 7, 2025, Teva Pharmaceutical Industries Ltd. announced its financial results for the first quarter of 2025. The announcement included details on the company's operations and financial condition for the period ending March 31, 2025. While specific financial figures are not detailed in the 8-K filing due to the absence of an attached press release, the filing references the information being furnished as Exhibit 99.1, which was not attached to this filing. Investors are directed to look for the press release for comprehensive financial details.
Get alerts for TEVA
Be first to know when TEVA files with the SEC.
Filing Categories
General Statement
No viable tag
Exhibits (1)
Advertisement
Official SEC Documents
TEVA Research
8Ks, insider trades, financials, technicals
SEC Alert Manager
Get alerts within 60 seconds of new filings
Advertisement